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Role of Transforming Growth Factor-a and the Epidermal Growth Factor Receptor
in Embryonic Rat Testis Development1
Elena Levine,3 Andrea S. Cupp, Linda Miyashiro, and Michael K. Skinner2
Center for Reproductive Biology, Department of Genetics and Cell Biology, Washington State University, Pullman,
Washington 99164-4231
ABSTRACT
Embryonic testis development requires the morphogenesis of
cords and growth of all cell populations to allow organ forma-
tion. It is anticipated that coordination of the growth and dif-
ferentiation of various cell types involves locally produced
growth factors. The current study was an investigation of the
hypothesis that transforming growth factor-a (TGF-a) is in-
volved in regulating embryonic testis growth. TGF-a has previ-
ously been shown to function in the postnatal testis. TGF-a and
other members of the epidermal growth factor (EGF) family act
through the epidermal growth factor receptor (EGFR) to stimu-
late cell proliferation and tissue morphogenesis. To understand
the potential actions of TGF-a in the embryonic testis, general
cell proliferation was investigated. Characterization of cell pro-
liferation in the rat testis throughout embryonic and postnatal
development indicated that each cell type has a distinct pattern
of proliferation. Germ cell growth was transiently suppressed
around birth. Interstitial cell growth was high embryonically and
decreased to low levels around birth. A low level of Sertoli cell
proliferation was observed at the onset of testis cord formation.
Sertoli cell proliferation in early embryonic development was
low; the levels were high later in embryonic development and
remained high until the onset of puberty. Both TGF-a and the
EGFR were shown to be expressed in the embryonic and post-
natal rat and mouse testis. Perturbation of TGF-a function using
neutralizing antibodies to TGF-a on testis organ cultures dra-
matically inhibited the growth of both embryonic and neonatal
testis. TGF-a antibodies had no effect on cord formation. The
TGF-a antibody was found to be specific for TGF-a in Western
blots when compared to EGF and heregulin. Testis growth was
also inhibited by perturbation of EGFR signaling using an EGFR
kinase inhibitor. Therefore, TGF-a appears to influence embry-
onic testis growth but not morphogenesis (i.e., cord formation).
Treatment of embryonic testis organ cultures with exogenous
TGF-a also perturbed development, leading to an increased pro-
liferation of unorganized cells. Testis from EGFR and TGF-a
knockout mice were analyzed for testis morphology. TGF-a
knockout mice had no alterations in testis phenotype, while
EGFR knockout mice had a transient decrease in the relative
amount of interstitial cells before birth. Observations suggest
that there may be alternate or compensatory factors that allow
testis growth to occur in the apparent absence of TGF-a actions
in the mutant mice. In summary, the results obtained suggest
that TGF-a is an important factor in the regulation of embryonic
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testis growth, but other factors will also be involved in the pro-
cess.
INTRODUCTION
The development of the testis requires coordination of
the growth and differentiation of several cell types. The
testis is formed initially from an undifferentiated bipotential
gonad (i.e., embryonic Day [e]13 in the rat). At this stage
it is indistinguishable from the ovary and possesses no mor-
phological organization. The first sign of male development
is the differentiation of precursor Sertoli cells, which then
aggregate with germ cells and undergo a transition from
mesenchyme to epithelia to form cords (i.e., e13.5 to e14
in the rat) [1, 2]. The testis cords remain solid until a lumen
forms after the onset of puberty (i.e., postnatal Day 10 in
the rat) to convert them into tubules (i.e., postnatal Days
14 to 18 in the rat). The seminiferous tubules are the site
of spermatogenesis, in which spermatogonia develop into
spermatozoa in close interaction with the Sertoli cells that
make up the walls of the tubule [3–5]. Surrounding the
Sertoli cells is a layer of peritubular myoid cells that are
responsible for contraction of the tubule [6–8) and regula-
tion of differentiated function [9, 10]. In the interstitial
space between the tubules are Leydig cells, stromal fibro-
blasts, vascular and lymphatic endothelial cells, and mac-
rophages [9].
Dramatic growth occurs in the testis during embryonic
and early postnatal development [11]. One of the earliest
male-specific characteristics of the testis after the formation
of cords is rapid growth. This extensive growth does not
occur in the ovary [12]. The peak of Sertoli cell prolifer-
ation occurs in the late embryo at e20–21 just before birth
[13]. This proliferation in the embryonic and early postnatal
period is crucial for establishing the mature adult size of
the testis since no Sertoli cell proliferation occurs after ini-
tiation of puberty [14, 15]. In addition, this proliferation is
necessary for reproductive function, since a sufficient pop-
ulation of Sertoli cells is necessary for adequate sperm pro-
duction in the adult [13, 16, 17]. The majority of informa-
tion about testicular growth regulation has concerned post-
natal growth or occasionally late embryonic growth [11,
13–19]. Several growth factors have been identified in the
postnatal testis and are postulated to be involved in the
regulation of puberty and spermatogenesis [9, 20, 21]. The
current study was an investigation of growth in the embry-
onic testis.
One family of growth factors that may play a role in
embryonic testis growth is the epidermal growth factor
(EGF) family. There are multiple related ligands in this
family, including EGF, transforming growth factor a (TGF-
a), amphiregulin, heparin-binding EGF, crypto, betacellu-
lin, and heregulin [22–24]. The receptors include the epi-
dermal growth factor receptor (EGFR/HER1/erbB1),
HER2/neu, HER3, and HER4 [25, 26]. The EGFR family
of receptors function by ligand-dependent dimerization and
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activation of the tyrosine kinase in the cytoplasmic domain
[27, 28]. EGF and its related ligands are capable of induc-
ing proliferation, differentiation, and migration in many dif-
ferent cell types [29]. The EGF family, and particularly the
heregulin receptors, have been associated with stimulation
of proliferation and malignant transformation. In addition,
these factors are known to stimulate growth and morpho-
genesis in several developing systems including the kidney,
lung, mammary gland, and microvascular endothelial cells
[30–36].
EGF and the related ligand transforming growth factor
a (TGF-a) are expressed in the postnatal testis [37–42].
TGF-a and EGF have various effects on the proliferation,
differentiation, and migration of Sertoli, Leydig, and peri-
tubular cells [37, 39, 43]. Although they have not been as
well characterized, other members of the EGF/TGF-a fam-
ily are also found in the testis [26, 44, 45]. Since the TGF-
a/EGF family of ligands have the ability to stimulate both
growth and morphogenesis, they have the potential to play
a critical role in early testis development. The current ex-
periments were designed to investigate the hypothesis that
the TGF-a family of growth factors has a role in embryonic
testis development.
MATERIALS AND METHODS
Dissections and Organ Cultures
Timed-pregnant Sprague-Dawley rats were obtained
from Charles River (Wilmington, MA). Plug date was con-
sidered to be embryonic Day 0 (e0). For e13 dissections,
gonads were dissected out with the mesonephros; for later-
stage dissections, testes alone were dissected. The organs
were cultured at 378C in 5% CO2 in drops of medium on
Millicell CM filters (Millipore, Bedford MA) floating on
the surface of 0.5–1 ml of CMRL 1066 medium (Gibco
BRL, Gaithersburg, MD) supplemented with penicillin-
streptomycin, insulin (10 mg/ml), and transferrin (10 mg/
ml). Antibodies and factors were added directly to the cul-
ture medium. The medium was changed every 1 or 2 days.
Cultures of e13 gonads 1 mesonephros were incubated for
3 days, by which point cords were well developed; e14
testis cultures were incubated for 4 days. For e18 and post-
natal Day 0 (0d) organ cultures, the testes were cultured as
fragments (halves of e18 testes and eighths of 0d testes),
since entire testes were too large to culture intact without
considerable necrosis in the centers. The tunica was re-
moved from 0d testis before culturing. The testes collected
for morphological analysis prior to cell culture were fixed
and processed immediately after microdissection or were
obtained from whole embryos that had been fixed prior to
microdissection. All procedures were approved by the ap-
propriate University Animal Care committees.
Testis Suspension and Reaggregation
To generate a testicular suspension from 0d testis, the
tunica was removed and the testes were digested with
0.125% trypsin, 0.1% EDTA, and 0.02 mg/ml DNase in
Hanks’ Balanced Salt Solution (HBSS) for 15 min at 378C.
The trypsin was inactivated with 10% calf serum. The sam-
ples were triturated with a pipette tip and washed twice in
1 ml HBSS by resuspending, spinning for 2 min, and re-
moving the supernatant. The remaining pellet was resus-
pended in a small volume (10 ml from 6–7 pooled testes)
and contained a single-cell suspension according to visual
inspection under a microscope. Drops of 2 ml of this sus-
pension were cultured and allowed to reaggregate on float-
ing filters as for intact organs.
Genomic DNA Isolation and Polymerase Chain Reaction
(PCR) for SRY
To determine the sex of e13 gonads, embryonic tails
were collected to make genomic DNA by standard proce-
dures. Briefly, the tissue was homogenized through a 25-
gauge needle in digestion buffer (100 mM NaCl, 10 mM
Tris, pH 8, 25 mM EDTA, 0.5% SDS) and digested with
proteinase K (0.15 mg/ml) for at least 4 h at 608C. The
samples were then extracted twice with an equal volume of
phenol:chloroform:isoamyl alcohol (25:24:1) and once with
chloroform:isoamyl alcohol. The DNA was precipitated by
adding 1/10 volume 7.5 M NH4Ac and 3 volumes cold
ethanol and incubating at 2808C for 1 h before centrifu-
gation at 48C for 30 min. Pellets were dried and resus-
pended in 10 ml H2O. PCR was performed by using 1 ml
of genomic DNA with the consensus SRY primers 59
CGGGATCCATGTCAAGCGCC CCATGAATGCATT-
TATG 39 and 59 GCGGAATTCACTTTAGCCCTCCGAT-
GAGGCTGA TAT 39, producing a PCR product of 240
base pairs (bp). PCR was performed using an annealing
temperature of 558C for 30 cycles.
RNA Isolation and Reverse Transcription-Polymerase
Chain Reaction (RT-PCR)
RNA for RT-PCR was obtained by freezing samples on
dry ice and then using the Tri Reagent (Sigma Chemical
Co., St. Louis, MO) for RNA isolation. Reverse transcrip-
tion was performed using murine Moloney leukemia virus-
RT under standard conditions. RT-PCR was performed for
EGFR at 608C annealing temperature for 30 cycles and for
TGF-a at 658C for 5 cycles followed by 558C for 30 cycles.
The EGFR primer sequences were 59TGCGpTCTCTTG-
CCGGAATGTCAG39 and 59GCAGTGGGGGCCGTCA-
ATGTAGT39, producing a PCR product of 205 bp. The
TGF-a primer sequences were 59ACCCTTTATCACACA-
GTTTT39 and 59CCCTGGCTGTCCTC ATTATCACCTG
39, producing a PCR product of 380 bp. The identity of the
PCR products was confirmed by restriction digests.
Embedding, Histology, and Immunocytochemistry for
Proliferating Cell Nuclear Antigen (PCNA)
Tissues were fixed in Histochoice (Amresco, Solon, OH)
and embedded in paraffin or in JB4 (Polysciences, War-
rington, PA) according to standard procedures. Sections
were stained with hematoxylin and eosin (paraffin sections)
or with toluidine blue (JB4 sections) according to standard
procedures. Immunocytochemistry for PCNA was per-
formed according to standard procedures. Briefly, 7-mm
sections were deparaffinized and rehydrated, quenched in
20% methanol/3% hydrogen peroxide, and blocked in 5%
serum for several hours at room temperature before incu-
bation with primary antibody monoclonal anti-PCNA clone
PC10 (Sigma) at 1:500 dilution overnight at 48C. Second-
ary antibody (biotinylated sheep anti-mouse biotin from
Amersham Pharmacia Biotech, Piscataway, NJ) was de-
tected by using the Vectastain kit (Vector Laboratories, Bur-
lingame, CA) and diaminobenzadine. Slides were counter-
stained lightly with hematoxylin to visualize the tissue.
Labeling indices for the percentage of each cell type
stained for PCNA were calculated by counting random re-
gions on at least 3 different sections from 3 different ex-
479ROLE OF TGF-a/EGFR IN EMBRYONIC TESTIS GROWTH
periments. The total number of cells counted in specific
regions ranged from 155 to 396 Sertoli cells, 80 to 396
germ cells, 338 to 862 interstitial cells, and 139 to 306
peritubular cells. Counts were performed by two different
people independently for comparison, and data were com-
bined. Data are presented as the mean 6 SEM to assess the
percentage of stained cells. The data from the two individ-
uals generally compared as shown by the reproducibility of
the data.
DNA Assay
To assay the DNA content of organs, each organ was
sonicated in 100 ml ethidium bromide buffer (EBB; 20 mM
NaCl, 5 mM EDTA, 10 mM Tris, pH 7.5) and stored at
2208C. DNA content then was determined fluorometrically
with ethidium bromide as previously described [37]. Brief-
ly, 0.25 nM ethidium bromide and 100 units/ml heparin in
EBB were added to each sample; samples were vortexed
and incubated for 15 min at room temperature. Fluorescent
emission was measured and quantified by using a standard
curve with calf thymus DNA from 0.5 mg to 6 mg DNA.
Imaging and Area Quantification
Images of whole organs were obtained by using a Lu-
mina digital scanning camera (Leaf Systems, Southbor-
ough, MA). Area was calculated by using Adobe Photoshop
(Mountain View, CA). To determine the relative percentage
of interstitium in testis, representative sections were imaged
and analyzed using Adobe Photoshop. The outline of each
cord was traced and the area within each was calculated,
as was the total area. The percentage of interstitium was
calculated as area cords/total area.
Western Blotting
Western blotting was performed according to standard
procedures. Protein samples were electrophoresed on a 8–
25% Phast gradient gel (Phast System; Pharmacia, Ala-
meda, CA) and transferred to nitrocellulose by using the
PhastTransfer semidry electrophoretic transfer unit (Phar-
macia). After blocking overnight in 5% dry milk/1% gly-
cine/0.05% Nonidet P-40 (NP40) in 50 mM Tris-HCl (pH
7.4)/0.15 M NaCl (TBS), the primary antibodies against
TGF-a were incubated with the blots for 4 h. After three
washes in TBS/NP40 and one in TBS, the blots were in-
cubated with secondary antibody anti-sheep conjugated to
horseradish peroxidase (Sigma) at 1:3000 for 1 h. After
three washes in TBS/NP40, one in TBS, and three in water,
detection was carried out using the ECL system (Amer-
sham).
Reagents
The antibodies against TGF-a (S574 raised against rat
TGF-a and S509 raised against human TGF-a) were ob-
tained from East Acres Biological (Southbridge, MA).
These TGF-a antibodies have been shown to be neutraliz-
ing polyclonal antibodies and to cross-react with mouse,
rat, human, and bovine TGF-a and not to cross-react with
EGF, amphiregulin, TGF-b, or fibroblast growth factor
(FGF) on Western blots (East Acres Biological). The EGFR
inhibitor AG1478 was obtained from Calbiochem (La Jolla,
CA). AG1478 is a highly selective competitive inhibitor of
ATP binding to the EGFR. The in vitro IC50 for EGFR is
3 nM, while the IC50 for HER2 and the platelet-derived
growth factor receptor are greater than 100 mM. TGF-a and
recombinant human heregulin-a were obtained from R&D
Systems (Minneapolis, MN). TGF-a knockout mice were
provided generously by Dr. Gerald Cunha (University of
California at San Francisco [UCSF], San Francisco, CA),
who maintains a colony of mice previously developed [19].
EGFR knockout mice were provided generously by Zena
Werb and Rik Derynk (UCSF) and by Terry Magnuson
(Case Western University, Cleveland, OH).
Statistical Analysis
All the data were obtained from a minimum of three
different experiments unless otherwise stated. Each data
point was converted to a mean and SEM from multiple
experiments determined as indicated in the figure legends.
Data were analyzed by a Student’s t-test or ANOVA as
indicated in the figure legends. Different superscript letters
denote a statistical difference.
RESULTS
Proliferation Pattern in Developing Testis
Investigation of the effects of a particular factor on
growth in the developing testis requires an understanding
of the overall pattern of growth of different cell types at
various stages of development. The cell populations that
are proliferating provide potential targets for the locally
produced growth factors (e.g., TGF-a). The pattern of cell
proliferation in the early rat testis was determined by using
immunocytochemistry for PCNA (Fig. 1). PCNA is an aux-
iliary protein of DNA polymerase that is required for DNA
replication during S-phase and therefore is expressed only
in proliferating cells [46–48]. The earliest time examined
was e14, which is the earliest point at which the testis is
distinguishable morphologically from the ovary, just after
cords have formed (Fig. 1A). Additional time points were
examined through late embryonic and early postnatal de-
velopment up to the early pubertal period of 20 days post-
natal (20d). The pattern of PCNA staining changed during
embryonic and early postnatal development (Fig. 1). At e14
(Fig. 1A), many cells in both the cords and the interstitium
expressed PCNA, although many of the Sertoli nuclei that
were lined up at the edges of the cords were unstained. By
e16 (Fig. 1B), all cells in the cords were stained, as were
the peritubular cells surrounding the cords. The interstitium
contained both PCNA-positive and PCNA-negative cells.
The pattern at e18 (Fig. 1C) was similar except that more
germ cells in the centers of the cords did not stain. This
high percentage of PCNA-positive cells throughout the late
embryonic testis is consistent with the rapid growth of the
organ. At birth (0d; Fig. 1D) there was little staining of
interstitial, peritubular, or germ cells, but almost all Sertoli
cells were stained. By 5d (Fig. 1E), the cells in the cords
have proliferated so that the cords occupy much more of
the area of the testis than in the embryonic testis. The Ser-
toli cells were still stained heavily for PCNA, and some
germ cells had begun expressing PCNA again. At 10d (Fig.
1F), some Sertoli cells had left the cell cycle; at 20d, the
Sertoli cells did not stain (data not shown). Similar results
were obtained with the adult 60d testis (data not shown).
Various spermatogenic cells were stained, including sper-
matogonia at the outside edges of the tubules and more
centrally located spermatocytes. In addition, meiotic figures
were visible. A high magnification of 10d testis is presented
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FIG. 2. Labeling indices of the percentage of PCNA-positive cells for
each cell type at various stages of development. Labeling indices were
calculated by counting stained and unstained cells in random regions of
replicate slides from at least 3 different sections in 3 different experiments.
Data are presented as the mean 6 SEM.
FIG. 3. Expression of TGF-a and EGFR mRNA by RT-PCR in the devel-
oping testis. Lanes 1–5, TGFa; lanes 6–9, EGFR. Individual lanes: 1, mo-
lecular weight markers; 2, e14; 3, e18; 4, 0d; 5, no template; 6, e14; 7,
e18; 8, 0d; 9, no template. The sizes of the PCR products were 380 bp
for TGF-a and 205 bp for EGFR. Representative of at least 3 different
experiments.
b
FIG. 1. PCNA immunocytochemistry in the developing rat testis; (G)
high magnification of F. PCNA-positive cells are brown while negative
cells are purple from hematoxylin counterstain. H) A negative control e18
hematoxylin stain. Representative cells: P, peritubular cell; S, Sertoli cell;
G, germ cell; L or I, interstitial cell. G) Two different stages of germ cell
are labeled (spermatogonia and spermatocyte). 3200 except for G, which
is 3400. Representative of at least three different experiments done in
replicate.
in Figure 1G to show specific cell populations. A control
background stain with nonimmune IgG is shown in Figure
1H.
Labeling indices were calculated at ages e14, e18, 0d,
5d, and 10d to extend the observations with a calculation
of the nuclear PCNA staining pattern and ratio of cells
stained (Fig. 2). Proliferation decreased in germ cells by
e18, was minimal at 0d, and returned to high levels by 5d
postnatal. The interstitium proliferated from the initiation
of testis development through the late embryo and de-
creased substantially in the early postnatal period. Sertoli
cells did not appear to be proliferating at the time of cord
formation (e14) but proliferated extensively through the rest
of embryonic and early postnatal development until puber-
ty. The decrease of Sertoli cell proliferation at the onset of
puberty has been previously documented [14]. Peritubular
proliferation was high until after birth and then decreased
dramatically. Observations suggest that all the testis cell
populations provide potential targets for locally produced
growth factors (e.g., TGF-a).
Expression of TGF-a and EGFR in the Embryonic Testis
Both TGF-a and EGFR are expressed in the postnatal
testis. To investigate their presence in the embryonic rat
testis, RNA was isolated from testes of various ages and
RT-PCR was performed. RT-PCR for TGF-a and EGFR
(Fig. 3) demonstrated that both genes were expressed
throughout embryonic testis development at e14, e18, and
0d. Similar results were obtained from e14 and 0d mouse
testis RNA (data not shown).
Immunocytochemistry was performed to confirm the ex-
pression of the TGF-a and EGFR proteins. TGF-a and
EGFR immunocytochemistry utilized sections from 0d rat
testis. The TGF-a and EGFR were primarily localized to
the interstitial cells with lower levels of staining in the
cords (Fig. 4). Preabsorbtion of the TGF-a antibody with
excess TGF-a eliminated the staining detected in the im-
munocytochemistry (data not shown). Observations sug-
gested that interstitial cells and to a lesser extent the cords
in the 0d testis express the TGF-a and EGFR proteins and
supported the mRNA data presented in Figure 3. In addi-
tion, the specificity of the TGF-a antibody was indicated
by the immunocytochemistry control.
Functional Perturbation of Embryonic Testis Development
with TGF-a-Neutralizing Antibody
To investigate whether TGF-a is important for stimulat-
ing the growth of the embryonic testis, organ cultures of
the embryonic testis were established. Growing the testes
in organ culture allowed direct perturbation of their devel-
opment. Testes from e14 embryos grew during 4 days in
culture and maintained their cord structure. Testes from e13
embryos cultured with the mesonephros developed cords
over 3 days in culture (Fig. 5A). The top part of the mi-
crograph (marked ‘‘T’’) is the testis connected to the lower
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FIG. 4. TGF-a (B), EGFR (C), and control nonimmune IgG (A) immu-
nocytochemistry on 0d testis sections. TGF-a- and EGFR-positive cells are
dark grey/black. 3100 (published at 93%). Representative of at least 2
different experiments.
darkly shaded mesonephros (Fig. 5B). The ability to ob-
serve the cords and their lighter appearance were likely due
to the comparatively less dense cell population in the cords
than in the interstitium.
Two different neutralizing antibodies to TGF-a were
used to treat embryonic testes placed in culture at e14 when
cords were already present. These TGF-a antibodies have
previously been shown not to cross-react with other EGF-
like factors such as EGF and amphiregulin. In addition,
these are neutralizing antibodies. The antibodies to TGF-a
(i.e., IgG fraction) caused dramatic inhibition of growth
compared to the control nonimmune IgG (Fig. 5). The cords
were not disrupted by the TGF-a antibody (Fig. 5C,D).
Various titers of TGF-a antibody (i.e., IgG fraction) were
used, and the optimal titer (1:8000 dilution) is presented.
The lighter-colored cord structures in the tissue are indi-
cated with arrows (Fig. 5C, D). As suggested above, the
lighter staining in the cords was likely due to a decreased
number of nuclei and cells. These are isolated testes devoid
of mesonephros in comparison to those in Figures 5A and
5B. Therefore, the morphology of the testis in Figures 5B
and 5D are different owing to absence of the mesonephros
and manipulation of the tissue in Figure 5B. The effect on
total tissue or cell growth was quantified by determining
the DNA content of organs as an estimate of cell numbers.
DNA content was determined at the time of initial dissec-
tion and after 4 days in culture with nonimmune IgG or
anti-TGF-a antibody (Fig. 6A). There was a 2.5-fold in-
crease in DNA content in the untreated testes or in testes
treated with nonimmune IgG. In contrast, there was almost
no growth in the TGF-a antibody-treated organs. A second
independent measure of cell growth was performed by vid-
eo imaging of the organs into a computer followed by quan-
tification of the area of the images (Fig. 6B). Two indepen-
dently raised antibodies to TGF-a gave the same inhibition
of testis growth (data not shown).
PCNA immunocytochemistry was performed to examine
the general proliferation of cells in the TGF-a antibody-
treated (i.e., IgG fraction) organ cultures (data not shown).
There was less PCNA staining, indicating fewer prolifer-
ating cells in the testis treated with TGF-a antibody. After
4 days in culture the PCNA expression in both the cords
and the interstitium was quantified. Labeling indices re-
vealed a significant decrease in the percentage of prolifer-
ating Sertoli cells and interstitial cells (Fig. 7).
Examination of the Role of TGF-a at the Initiation of
Testis Development
TGF-a appears to be important in stimulating the growth
of the testis from the earliest point at which the testis is
distinguishable from an ovary. Inhibiting TGF-a at this
stage did not disrupt testis cords. This observation suggests
that TGF-a is not necessary for the maintenance of testis
cords. To investigate whether TGF-a is required for the
formation of cords, organ cultures of embryonic gonads
with mesonephros were established early on e13 before
cords had formed. Organ cultures of e13 testes and meso-
nephros were treated with the antibody (i.e., IgG fraction)
to TGF-a to determine whether inhibiting TGF-a at this
stage would interfere with cord formation (Fig. 8). The an-
tibody to TGF-a was functional in these cultures, since in-
hibition of growth was observed. However, there was no
effect on cord formation. There was no delay in the timing
of the appearance of cords (examined every 12 h) (Fig. 8).
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FIG. 5. E13 testis 1 mesonephros organ
cultures after 1 day (A) and after 3 days
(B) in culture. The upper structure (T) is
the testis attached to the lower, dark-col-
ored mesonephros (M). Representative of
more than 10 different experiments. The
diameter of the organ was approximately
1000 mm. E14 testis organ cultures treated
with control nonimmune IgG (C) or with
anti-TGF-a IgG antibody S574 (D) after 4
days in culture. Representative cords are
marked by arrows placed on the lighter-
colored structures and are shown in C and
D. This is a microdissected testis devoid of
mesonephros with some manipulation in
comparison to that shown in A and B.
Representative of 10 experiments.
FIG. 7. Labeling index for the percentage of each cell type positive for
PCNA on e14 testis organ cultures treated with control nonimmune or
anti-TGF-a antibody for 4 days. Labeling indices were calculated by
counting stained and unstained cells in random regions of at least 3 dif-
ferent sections from 3 different experiments. ** Statistically significant dif-
ference from control (P , 0.001); * statistically significant difference from
control (P , 0.02) as determined by a t-test.
FIG. 6. Quantitation of e14 testis organ cultures treated with control non-
immune IgG or with anti-TGF-a IgG antibody S574 for 4 days in culture.
(A) DNA content of the organ cultures; (B) area of the organ cultures. (A)
DNA content (mg) was measured by ethidium bromide fluorometry on
extracts of testis organ cultures. Data are presented as the mean 6 SEM
for 3 separate experiments with n 5 9 (Initial), n 5 21 (Control Ab), and
n 5 22 (TGF-a Ab). (B) Area (mm2) was measured using NIH Image after
1 day and after 4 days in culture. Data are presented as the mean 6 SEM
for 3 separate experiments with n 5 13 (Initial 5 1 day), n 5 23 (Control
Ab), and n 5 24 (TGF-a Ab). Different superscripts designate statistically
significant difference (P , 0.01) as determined by ANOVA.
Investigation of the Role of TGF-a Later in Embryonic
and Perinatal Development
In order to determine whether TGF-a is required for tes-
tis growth in perinatal development, testis organ cultures at
later embryonic ages were treated with an antibody to TGF-
a and assayed for DNA content as a measure of cell num-
ber. There was still dramatic inhibition of testis growth at
e18 by the antibody to TGF-a (Fig. 9A). The control organs
treated with nonimmune IgG exhibited only about a 1.5-
fold increase in DNA content after 6 days in culture instead
of the 2.5-fold increase seen with e14 testis. The antibody
to TGF-a abolished all growth. The smaller increase in size
of the control organs may reflect a decreased growth and/
or a limitation on growth in the organ culture system. The
0d testes grew less, and growth was inhibited partially by
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FIG. 8. E13 testis 1 mesonephros organ cultures treated with control
nonimmune IgG or anti-TGF-a IgG antibody S574 for 3 days. (A) Control
nonimmune IgG; (B) anti-TGF-a IgG antibody. T, testis; M, mesonephros.
A and B are the same magnification. Representative of 4 different exper-
iments.
c
FIG. 9. Effects of control nonimmune IgG or anti-TGF-a antibody S574
on the growth of e18 (A) and 0d (B) testis. DNA content (mg) was deter-
mined at the time of dissection (initial) or after 4 days in culture. A) Mean
6 SEM for 2 separate experiments with n 5 22 for all conditions. (B)
Mean 6 SEM for 3 separate experiments with n 5 28 (initial) and n 5
29 (control Ab and anti-TGF-a antibody) using 1/8 of testis. (C) Effects of
EGFR tyrosine phosphorylation inhibitor AG1478 (160 nM) or control sol-
vent dimethyl sulfoxide (DMSO) on the growth of e14 testis cultured for
4 days; mean 6 SEM for 3 separate experiments with n 5 13 (initial), n
5 14 (DMSO), and n 5 15 (AG1478). Different superscripts designate
statistically significant differences (P , 0.01) as determined by ANOVA.
the antibody to TGF-a (Fig. 9B). Observations suggest that
TGF-a is important for testis growth throughout embryonic
development and in early postnatal development.
Perturbation of the EGFR by a Tyrphostin Inhibitor
To confirm the importance of TGF-a in testis growth, an
independent approach of perturbing the EGFR signaling
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FIG. 10. Effects of exogeneous TGF-a (50
ng/ml) on testis cultures. A,B) E14 testis
cultured for 4 days in the absence (A) or
presence (B) of TGF-a (40 ng/ml). Repre-
sentative of 5 different experiments. (C,D)
Dissociation-reaggregation cultures of 0d
testis in the absence (C) or presence (D) of
TGF-a (100 ng/ml). Representative of 2
different experiments. Representative cords
are marked by arrows. The ring of unorga-
nized tissue around the edge in B and D
is marked by arrowheads.
pathway was used. The action of the EGFR was blocked
with use of a highly selective tyrosine kinase inhibitor of
the tyrphostin family known as AG1478 [49, 50]. Treat-
ment of e14 testes in organ culture with 160 nM AG1478
resulted in a striking inhibition of growth (Fig. 9C). Treat-
ment with 80 nM AG1478 was found to be less effective,
although it resulted in some inhibition of growth (data not
shown). Similar growth inhibition was apparent when 0d
testis cultures were treated with AG1478 (data not shown).
Observations suggest that the TGF-a receptor EGFR is re-
quired for optimal embryonic testis growth.
Effect of Exogeneous TGF-a on Testis Organ Cultures
If TGF-a is important in promoting the proliferation of
cells in the embryonic testis, exogeneous TGF-a may in-
fluence testis growth. Testis organ cultures at e14 were
treated with 50 ng/ml of TGF-a and then stained for PCNA
to determine whether there was an increase in the number
of proliferating cells. A 25-ng/ml and a 100-ng/ml dose of
TGF-a gave results similar to those with the 50-ng/ml dose
(data not shown). Addition of TGF-a to the culture medium
caused a ring of unorganized tissue around the edge of the
organ (Fig. 10A, B). Immunocytochemistry for PCNA
demonstrated that almost all the cells in the outer ring were
proliferating (data not shown). This suggests that cells in
the embryonic testis are capable of responding to exoge-
neous TGF-a by inducing additional proliferation. The
same effect was seen with reaggregated cultures of a cell
suspension from a 0d testis. When a 0d testis was disso-
ciated to single cells and the cells were allowed to reag-
gregate on a floating filter, cords reformed in the aggregate
(Fig. 10C). When these cultures were treated with exoge-
neous TGF-a, a ring of unorganized cells developed around
the edge just as in the intact testis organ cultures (Fig. 10C,
D).
Examination of Testis from EGFR and TGF-a
Knockout Mice
The data with the neutralizing antibodies suggested that
TGF-a is critical for growth of the early embryonic testis.
Since TGF-a functions through the EGFR, it was possible
that EGFR knockout mice might show a defect in testis
growth. Testis from EGFR knockout mice were examined
at several ages starting with e13 (the equivalent of e15 in
the rat). Despite dramatic effects on other organs and on
the overall size of the EGFR knockout mice [51–53], the
testes were grossly normal (Fig. 11). There was apparently
no decrease in size in the early embryonic testis compared
to that in wild-type littermates. Later in development there
was some decrease in size, but it was less than the overall
decrease in size of the animals (data not shown). It appears
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FIG. 11. A) E18 wild-type (WT) and B) e18 knockout (KO) mice testes.
JB4 sections were stained with toluidine blue. 3200 (published at 80%).
Data are representative of more than 10 sections from different testes.
FIG. 12. Quantitation of percentage interstitium in EGFR knockout and
wild-type testes from e18 and 0d mice. Computer analysis of the area of
the interstitium was performed by subtracting the combined areas of the
cords from the total area of each testis section. Data are presented as the
mean 6 SEM; numbers of different testes analyzed were n 5 11 (e18
WT), n 5 16 (e18 KO), n 5 9 (0d WT), and n 5 8 (0d KO). The e18 mice
were from two independently produced knockout mouse lines. Different
superscripts designate statistically significant difference (P , 0.01) as de-
termined by ANOVA.
that the testis is able to compensate for the lack of the
EGFR.
When sections through the testes were examined, there
appeared to be a subtle effect on the growth of the inter-
stitium in the EGFR knockout mice. Less interstitium was
present in the knockout mice than in the wild-type litter-
mates (Fig. 11). Quantitation of this effect revealed that at
e18 there was approximately a 20% decrease in the per-
centage of interstitium in the EGFR knockout testis (Fig.
12). The difference in the area of the interstitium observed
was found to be due to a decrease in cell number through
quantitation of cell numbers in selected sections (data not
shown). In the 0d testis, the difference between the area of
the interstitium in the wild-type and knockout testis was
not significant (data not shown). Therefore, the EGFR
knockout testis phenotype is a transient decrease in inter-
stitial cell growth late in embryonic development.
In contrast, testes from TGF-a knockout mice appeared
normal at the developmental stages examined in compari-
son to normal littermates (data not shown). Although the
EGFR knockout phenotype supports a role for EGF family
ligands in the developing testis, combined data suggest that
alternate and/or compensating TGF-a-related ligands and/
or EGFR-related receptors appear to be present.
TGF-a Antibody Specificity
The presence of TGF-a antibody resulted in complete
inhibition of testis growth. This neutralizing TGF-a anti-
body has previously been shown to not cross-react with
EGF, amphiregulin, TGF-b, or FGF. The inability of the
antibody to react with other EGF-like ligands such as EGF
or amphiregulin suggests a high degree of specificity; how-
ever, reactivity with another EGF-like ligand, heregulin, has
not been shown. To further examine whether the antibodies
to TGF-a are able to recognize related ligands, a Western
blot was performed. The antibodies to TGF-a were found
to react only with TGF-a and not with either EGF or her-
egulin-a (Fig. 13). A Western blot of Day 0 testis showed
the 25-kDa precursor and 6-kDa mature forms of the TGF-
a protein (data not shown). Therefore, the TGF-a antibod-
ies appear specific with the factors tested thus far.
DISCUSSION
The results provide information about the control of
growth during embryonic testis development. Immunocy-
tochemistry for the proliferation marker PCNA confirmed
the dramatic growth of the embryonic testis. Each cell type
had its own temporal pattern of proliferation. During late
embryonic development, almost all somatic cells were pro-
liferating both in the cords and in the interstitium. The num-
ber of proliferating cells decreased first in the interstitium.
A high percentage of proliferating cells continued to be
found in the Sertoli cell population through early postnatal
development, decreasing by 10 days at the onset of pubertal
testis development. Germ cell proliferation was extensive
at e14 and e16, decreased by e18, and then stopped until
the early postnatal period, at which point it increased
through 20d development. Therefore, all the testis cell types
provide targets for locally produced growth factors such as
TGF-a.
These observations based on PCNA as a marker of pro-
liferating cells confirmed earlier experiments in which mi-
totic figures were quantified [14] and the incorporation of
tritiated thymidine was examined [13, 15]. The only differ-
ence from the previous data is that the experiments dem-
onstrated mitotic arrest of the germ cells by e18 [13, 54].
In the previous thymidine incorporation experiments, e18
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FIG. 13. Western blot with anti-TGF-a antibodies S574 and S509 of
recombinant TGF-a, EGF, and heregulin-a (300 ng each). A) SDS gel
stained with Coomassie Blue. B) Western blot with anti-TGF-a antibody
S509. C) Western blot with anti-TGF-a antibody S574. A,B,C) Lanes: 1,
molecular weight markers; 2, heregulin-a; 3, EGF; 4, TGF-a. TGF-a and
EGF are 6 kDa and heregulin-a is 7 kDa.
germ cells did not stain positive, whereas in the current
study, e18 germ cells stained positive for PCNA. A limi-
tation to the use of PCNA is that the protein is retained by
the cell for a period after cell proliferation. Therefore,
PCNA is a marker of general cell growth, and some PCNA
likely remains after mitotic arrest in male germ cells. A
similar observation has been made for female germ cells,
since there is PCNA staining in the oocyte while it is in
meiotic arrest [55]. PCNA staining has been shown to cor-
relate extremely well with cell proliferation, but it is also
involved in DNA repair [47, 55–58]. Increased levels of
DNA repair in germ cells could also explain the persistence
of PCNA at e18. Therefore, the PCNA data presented con-
firm the previous studies, and the difference at e18 is likely
a technical limitation to the use of PCNA. The extensive
cell proliferation suggests a need for stimulators of growth
in the embryonic testis. This dramatic growth is sex-spe-
cific, since the ovary grows very little during late embry-
onic development [12]. In addition, the differences in the
timing of proliferation of the various cell types suggests the
need for the regulation of growth through local growth fac-
tors and receptors such as TGF-a and EGFR.
TGF-a was found to be important in stimulating the
growth of the embryonic testis. The growth of e14 testis in
organ culture was inhibited by either of two neutralizing
antibodies to TGF-a. Growth was measured by changes in
DNA content of the organs and was confirmed by measur-
ing the area of the organ. Quantitation by area is less ac-
curate since it is a two-dimensional measurement of a three-
dimensional tissue. However, it was still apparent that the
antibodies to TGF-a effectively inhibited the growth of e14
testis in organ culture. The neutralizing antibodies to TGF-
a and the EGFR inhibitor were still able to inhibit the
growth of late embryonic (e18) and perinatal (0d) testis.
This suggests that TGF-a ligand is important for growth
throughout early testis development. Immunocytochemistry
for PCNA in the organ cultures demonstrated that growth
of both Sertoli and interstitial cells is inhibited by the an-
tibodies to TGF-a. These observations suggest that TGF-a
is important for promoting growth of both cell types. How-
ever, the current experiments do not rule out possible in-
direct effects through various cell-cell interactions. The ex-
act location of TGF-a expression and action remain to be
determined.
Testis growth was also inhibited by the tyrphostin
AG1478, which is a specific inhibitor of the EGFR tyrosine
kinase. AG1478 is selective for the EGFR and does not
inhibit other growth factor receptor tyrosine kinases includ-
ing the related HER2 kinase at the concentrations used in
these experiments [49]. Inhibition of growth of the embry-
onic testis by AG1478, therefore, provides further evidence
for the importance of TGF-a-induced signaling in stimu-
lating testis growth.
Despite dramatic effects on embryonic testis growth,
neutralizing antibodies to TGF-a did not disrupt cord for-
mation in e13 testis. TGF-a and EGF have been implicated
in morphogenetic events in other systems involving tube
formation and branching such as the kidney, lung, mam-
mary gland, and endothelial cells [30–36]. Organ cultures
of early e13 testis and mesonephros are susceptible to the
inhibition of cord formation by serum [1, 59]. This dem-
onstrates the possibility of perturbing cord formation in tes-
tis organ cultures. The lack of an effect of the TGF-a an-
tibodies on the development of cords in the testis suggests
that TGF-a is not necessary for testis cord formation. If
TGF-a does play a role in testis cord formation, then other
factors must be able to compensate in the organ cultures.
Exogenous TGF-a was found to affect testis organ cul-
tures, implying that the cells are capable of responding to
TGF-a. There was not an overall increase in the size or
DNA content of the organ but an increase in disorganized
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cells around the outside of the testis. One reason could be
that TGF-a stimulates proliferation to such an extent that
the cells can no longer maintain the cord structure; another
could be an overstimulation of growth of the interstitium
such that it grows out beyond the cords. PCNA immuno-
cytochemistry of the organs treated with TGF-a revealed
an increase in the number of proliferating cells around the
outside of the testis, such that almost all the cells in this
region expressed PCNA. These observations support the
interpretation that TGF-a treatment preferentially increased
the proliferation of the more accessible cells on the outside
of the organs. Maintenance of the cord structure is clearly
compatible with some proliferation, since there is extensive
PCNA staining in the cords throughout late embryonic and
early postnatal development. However, it is possible that an
increased rate of proliferation causes a disruption of the
structure.
In contrast to the extensive inhibition of testis growth by
neutralizing TGF-a antibodies or inhibiting signaling
through the EGFR, the lack of EGFR in knockout mice did
not cause a significant inhibition of testis growth. The
EGFR knockout mice did show a dramatic inhibition of
growth of other organs and of the whole animal [51–53].
There was a decrease in the percentage of the interstitium
in late embryonic (e18) testis, suggesting that the growth
of the interstitium was slightly inhibited or delayed. This
effect was observed in two different EGFR knockout
strains. Interstitial volume and cell numbers were transient-
ly decreased. Observations suggest that the interstitial cells
may be more dependent on the presence of the EGFR for
growth and less able to compensate for its absence than
Sertoli cells.
There has been no evidence that TGF-a is capable of
interacting directly with any other related receptors. Pre-
viously, the TGF-a antibodies were shown to not cross-
react with EGF, amphiregulin, TGF-b, or FGF. The inability
to react with EGF suggests a high degree of specificity, but
reactivity to heregulin had not been examined. Western
blotting of both antibodies against recombinant human EGF
and heregulin-a failed to detect any cross reactivity. Al-
though the antibodies used appear specific, further investi-
gation is required to determine whether unidentified TGF-
a-related ligands may be recognized by the antibodies and
function normally in the stimulation of testis growth.
The observation that TGF-a is important for stimulating
the growth of the embryonic testis is significant because of
the importance of embryonic cell proliferation for adult tes-
tis size and fertility. FSH is the most active agent found to
promote testis growth and particularly Sertoli cell prolif-
eration. FSH in vitro can stimulate Sertoli cell proliferation,
and removal of FSH in vivo causes a dramatic decrease in
Sertoli proliferation in e18 testis [16, 17]. However, the ear-
liest detectable FSH in the pituitary and the earliest de-
tectable FSH receptors in the testis are in e17 rats [11].
Other factors must be responsible for promoting the growth
of the earlier testis development. These factors presumably
are produced locally, since testis growth is maintained in
organ culture. The current data imply that TGF-a is capable
of performing this function in the early embryonic testis.
In addition, it is not known what local testicular factors
might be involved in the response to FSH in the late em-
bryonic testis. b-Endorphin produced by Leydig cells has
been implicated in modulating the response to FSH, since
blocking its action increases the stimulation of e20 Sertoli
cell proliferation by FSH [17]. It is possible that TGF-a is
involved in the local mediation of FSH action, since the
TGF-a family appears to be important for testis growth in
the late embryo.
The involvement of other proteins such as basic FGF
and activin has been suggested in testis growth at particular
times in development. Basic FGF is expressed embryoni-
cally by both germ cells and Leydig cells beginning around
e16, so it is a potential mediator of local testis cell inter-
actions in the late embryo [60]. FGF increases the survival
of Sertoli cells in culture, but there are conflicting data on
whether it increases proliferation [61, 62]. Activin can en-
hance the proliferation of postnatal Sertoli cells, and activin
receptor knockouts show decreased testis size and a delay
in fertility [18, 63]. However, activin actually inhibits the
growth of e14 testis in organ culture [64]. The data suggest
that any promotion of growth by activin occurs postnatally,
but it may be a negative regulator of embryonic testis
growth. TGF-a is therefore one of the first factors impli-
cated thus far in the local promotion of early embryonic
testis growth.
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